Aptevo Therapeutics Inc. Restricted Cash
Aptevo Therapeutics Inc. (APVO) had Restricted Cash of $427.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets › Restricted Cash and Investments › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2023-03-30
- 2022-09-30: Restricted Cash $427.00K.
- 2022-06-30: Restricted Cash $546.00K.
- 2022-03-31: Restricted Cash $1.26M.
- 2021-12-31: Restricted Cash $1.26M.
| Period end | Restricted Cash |
|---|---|
| 2022-09-30 | $427.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $546.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.26M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.26M 10-K · filed 2023-03-30 |
| 2020-12-31 | $2.56M 10-K · filed 2022-03-24 |
| 2019-12-31 | $5.00M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |